CU20170046A7 - Proceso mejorado para la conjugación y conjugados sintéticos de oligosacarido-proteina novedosos obtenidos del mismo - Google Patents
Proceso mejorado para la conjugación y conjugados sintéticos de oligosacarido-proteina novedosos obtenidos del mismoInfo
- Publication number
- CU20170046A7 CU20170046A7 CUP2017000046A CU20170046A CU20170046A7 CU 20170046 A7 CU20170046 A7 CU 20170046A7 CU P2017000046 A CUP2017000046 A CU P2017000046A CU 20170046 A CU20170046 A CU 20170046A CU 20170046 A7 CU20170046 A7 CU 20170046A7
- Authority
- CU
- Cuba
- Prior art keywords
- oligosaccharide
- conjugation
- synthetic
- protein
- conjugates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a un procedimiento mejorado de conjugación para obtener conjugados sintéticos de oligosacárido-proteína (OS-PR). El proceso de conjugación sintética OS-PR es un proceso rápido que proporciona conjugados oligosacárido-proteína que son altamente inmunogénicos y provocan respuestas inmunes específicas y homogéneas. El oligosacárido sintético que comprende de cuatro a ocho unidades repetitivas de los respectivos monómeros y al menos un enlazador amino terminal incorporado, dicho polisacárido sintético imita al polisacárido natural obtenido a partir de bacterias gram negativas tales como los serogrupos A, C, Y, W, X de Neisseria meningitidis y Haemophilus influenzae y la proteína portadora que se obtiene a partir de bacterias gram positivas como Clostridium tetani (toxoide tetánico) o Corynebacterium diphtheriae (CRM197) o sus versiones recombinantes. La química de conjugación de dicho conjugado oligosacárido-proteína de la presente invención se da por una unión tioéter. La presente invención toma tiempo de proceso completo en el intervalo de 14-22 horas. Dichos conjugados oligosacárido-proteína son útiles en la producción de vacunas monovalentes o vacunas combinadas multivalentes y como herramienta de diagnóstico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2884DE2014 | 2014-10-09 | ||
PCT/IB2015/057682 WO2016055957A1 (en) | 2014-10-09 | 2015-10-08 | An improved process of conjugation and novel synthetic oligosaccharide- protein conjugates obtained thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CU20170046A7 true CU20170046A7 (es) | 2017-06-05 |
Family
ID=55652678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CUP2017000046A CU20170046A7 (es) | 2014-10-09 | 2015-10-08 | Proceso mejorado para la conjugación y conjugados sintéticos de oligosacarido-proteina novedosos obtenidos del mismo |
Country Status (18)
Country | Link |
---|---|
US (1) | US10105438B2 (es) |
EP (1) | EP3204396A4 (es) |
JP (1) | JP2017531662A (es) |
KR (1) | KR20170065030A (es) |
CN (1) | CN106795194A (es) |
AU (1) | AU2015329590B2 (es) |
BR (1) | BR112017006447A2 (es) |
CA (1) | CA2963900A1 (es) |
CL (1) | CL2017000844A1 (es) |
CO (1) | CO2017003291A2 (es) |
CU (1) | CU20170046A7 (es) |
EA (1) | EA201700177A1 (es) |
IL (1) | IL251511A0 (es) |
MX (1) | MX2017004495A (es) |
PH (1) | PH12017500579A1 (es) |
SG (1) | SG11201702451WA (es) |
TN (1) | TN2017000126A1 (es) |
WO (1) | WO2016055957A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170198004A1 (en) | 2014-05-24 | 2017-07-13 | Biological E Limited | Novel semi-synthetic meningococcal conjugate vaccine |
BR112018001425A2 (pt) * | 2015-07-28 | 2018-09-11 | Msd Wellcome Trust Hilleman Laboratories Pvt Ltd | novos oligômeros de sorogrupo y de neisseria meningitidis e processos de sintetização dos mesmos |
MX2019002489A (es) | 2016-09-02 | 2019-10-21 | Sanofi Pasteur Inc | Vacuna contra neisseria meningitidis. |
BR112019026192B1 (pt) | 2017-06-10 | 2022-05-10 | Inventprise, Llc | Vacinas de conjugado multivalente com polissacarídeos de conjugado bivalente ou multivalente que fornecem imunogenicidade e avidez melhoradas |
US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
JP7297047B2 (ja) * | 2018-03-23 | 2023-06-23 | コラネックス・キャピタル | 治療用ツールとしての精密なグリココンジュゲート |
CN113274488B (zh) * | 2021-04-30 | 2023-08-29 | 山东省药学科学院 | 一种特异性预防真菌感染的寡糖疫苗及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2434668A1 (en) * | 2003-07-04 | 2005-01-04 | Laurence Mulard | Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a |
RU2412944C2 (ru) * | 2005-05-06 | 2011-02-27 | Новартис Вэксинз Энд Дайагностикс Срл | Иммуногены для вакцин против менингита а |
FR2904627B1 (fr) * | 2006-08-04 | 2008-11-07 | Pasteur Institut | Nouveaux peptides actives, purifies et isoles, derives du recepteur cd4 (mini-cd4) et leur procece de preparation |
CA2819366A1 (en) * | 2010-12-10 | 2012-06-14 | Merck Sharp & Dohme Corp. | Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions |
GB201103836D0 (en) * | 2011-03-07 | 2011-04-20 | Glaxosmithkline Biolog Sa | Conjugation process |
-
2015
- 2015-10-08 CU CUP2017000046A patent/CU20170046A7/es unknown
- 2015-10-08 AU AU2015329590A patent/AU2015329590B2/en not_active Expired - Fee Related
- 2015-10-08 EA EA201700177A patent/EA201700177A1/ru unknown
- 2015-10-08 KR KR1020177012154A patent/KR20170065030A/ko unknown
- 2015-10-08 BR BR112017006447A patent/BR112017006447A2/pt not_active Application Discontinuation
- 2015-10-08 TN TN2017000126A patent/TN2017000126A1/en unknown
- 2015-10-08 SG SG11201702451WA patent/SG11201702451WA/en unknown
- 2015-10-08 MX MX2017004495A patent/MX2017004495A/es unknown
- 2015-10-08 CN CN201580054739.3A patent/CN106795194A/zh active Pending
- 2015-10-08 US US15/516,445 patent/US10105438B2/en not_active Expired - Fee Related
- 2015-10-08 CA CA2963900A patent/CA2963900A1/en not_active Abandoned
- 2015-10-08 WO PCT/IB2015/057682 patent/WO2016055957A1/en active Application Filing
- 2015-10-08 EP EP15849268.6A patent/EP3204396A4/en not_active Withdrawn
- 2015-10-08 JP JP2017518942A patent/JP2017531662A/ja active Pending
-
2017
- 2017-03-29 PH PH12017500579A patent/PH12017500579A1/en unknown
- 2017-04-02 IL IL251511A patent/IL251511A0/en unknown
- 2017-04-04 CO CONC2017/0003291A patent/CO2017003291A2/es unknown
- 2017-04-06 CL CL2017000844A patent/CL2017000844A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2015329590A1 (en) | 2017-05-04 |
EP3204396A4 (en) | 2018-03-28 |
TN2017000126A1 (en) | 2018-10-19 |
US20170246313A1 (en) | 2017-08-31 |
KR20170065030A (ko) | 2017-06-12 |
CL2017000844A1 (es) | 2017-12-22 |
AU2015329590B2 (en) | 2019-08-22 |
CO2017003291A2 (es) | 2017-06-30 |
IL251511A0 (en) | 2017-05-29 |
PH12017500579A1 (en) | 2017-08-30 |
EP3204396A1 (en) | 2017-08-16 |
US10105438B2 (en) | 2018-10-23 |
SG11201702451WA (en) | 2017-04-27 |
EA201700177A1 (ru) | 2017-07-31 |
BR112017006447A2 (pt) | 2017-12-12 |
JP2017531662A (ja) | 2017-10-26 |
CA2963900A1 (en) | 2016-04-14 |
WO2016055957A1 (en) | 2016-04-14 |
MX2017004495A (es) | 2017-12-18 |
CN106795194A (zh) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20170046A7 (es) | Proceso mejorado para la conjugación y conjugados sintéticos de oligosacarido-proteina novedosos obtenidos del mismo | |
PE20220774A1 (es) | Conjugados proteina-polisacarido de estreptococo grupo b, metodos para producir conjugados, composiciones inmunogenas que comprenden conjugados y sus usos | |
PH12019501552A1 (en) | Polypeptide-antigen conjugates with non-natural amino acids | |
MX2020002558A (es) | Procesos para la formulacion de polisacaridos neumococicos para la conjugacion a una proteina transportadora. | |
AR100859A1 (es) | Polisacáridos y sus usos | |
PE20161095A1 (es) | Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos | |
AR092896A1 (es) | Composiciones inmunogenicas | |
BR112018007812A2 (pt) | polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica. | |
BR112019001995A2 (pt) | composição de conjugado de polissacarídeo pneumocócico multivalente ? proteína | |
DOP2013000235A (es) | Proteínas de fusión y vacunas de combinación que comprenden proteína e y pilina a de haemophilus influenzae. | |
GB2455447A (en) | Method of producing meningococcal meningitis vaccine for neisseria meningitidis serotypes A, C,Y and W-135 | |
BR112012007984A2 (pt) | polinucleotídeo, vetor, célula hospedeira, polipeptídeo, processos para preparar uma toxina bacteriana, para a expressão periplásmica de um polipeptídeo recombinante, para fabricar um conjugado e uma vacina | |
IN2014DN09791A (es) | ||
AR090294A1 (es) | Composiciones de neisseria meningitidis y metodos de las mismas | |
MX2018010920A (es) | Nuevos conjugados de polisacarido-proteina, y procedimiento para obtener los mismos. | |
MX354103B (es) | Composicion inmunogenica. | |
MX2021014710A (es) | Un conjugado inmunogenico de polisacarido de neumococo del serotipo 35b- proteina y proceso de conjugacion para preparar el mismo. | |
PH12016500360A1 (en) | A bacterial vaccine and methods for manufacture thereof | |
MX337202B (es) | Vacunas de conjugado carbohidrato-glicolipido. | |
CY1123600T1 (el) | Μεθοδος θεραπειας | |
BR112019003419A2 (pt) | composição de vacina multivalente | |
MY194920A (en) | Polysaccharide ? protein conjugates with enhanced immunogenicity and rapid high yielding process thereof | |
BR112012007877A2 (pt) | meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis | |
EP3804749A3 (en) | Antigens and antigen combinations | |
BR112012004703A2 (pt) | regime de imunização inicial de reforço heterólogo contra o vírus da língua azul. |